Inex Medicaments Private Limited, a active private limited company, was established on 06 November 2009 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909TN2009PTC073452. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Gopalakrishnan Srinivasan (Managing Director), Banumathi Srinivasan (Director). Past directors included Ajithkumar, Prem Kumar Dhananjeyan, Obula Krishnan Muralidharan. It holds ₹2.25 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.22,Villa A&B, Second Floor Rajiv Street, Kamaraj Nagar, Keelkatta, Chennai, Tamil Nadu, 600117.
U51909TN2009PTC073452
073452
06 November 2009
₹0.50 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Inex Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gopalakrishnan Srinivasan | Managing Director | 06 Nov 2009 | Current |
| Banumathi Srinivasan | Director | 19 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Mar 2025 | Past |
| Pramod Abcsdd | Director | 27 Aug 2013 | Past |
| Pramod Abcsdd | Director | 27 Aug 2013 | Past |
| Pramod Abcsdd | Director | 27 Aug 2013 | Past |
| Pramod Abcsdd | Director | 27 Aug 2013 | Past |
| Pramod Abcsdd | Director | 27 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inex Medicaments Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.75% increase. The company also saw a slight improvement in profitability, with a 3.61% increase in profit. The company's net worth Soared by an impressive increase of 15.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Inex Medicaments had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,450,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2016 | Others | ₹2.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inex Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inex Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inex Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 22.45 M registered on 13 May 2016 with Charge ID 100038012 was modified on 26 Aug 2025. was documented.
The activity Banumathi Srinivasan was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 8 months 29 days . was completed.
Inex Medicaments Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Inex Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Others amounted to Rs. 22.45 M with Charge ID 100038012 was registered on 13 May 2016. was recorded as a recent event.
The activity Gopalakrishnan Srinivasan was appointed as a Managing Director was appointed as a Managing Director on 06 Nov 2009 & has been associated with this company since 16 years 1 month . was completed.
The CIN of Inex Medicaments Private Limited is U51909TN2009PTC073452.
Inex Medicaments Private Limited is headquartered at No.22,Villa A&B, Second Floor Rajiv Street, Kamaraj Nagar, Keelkatta, Chennai, Tamil Nadu, 600117.
Inex Medicaments Private Limited was incorporated on 06 November 2009.
The current directors of Inex Medicaments Private Limited are
The primary industry of Inex Medicaments Private Limited is Trade.
Inex Medicaments Private Limited is unlisted.
The authorized capital of Inex Medicaments Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Inex Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX